TriGalNAc CBz is a protected, benzoyl ester-functionalized GalNAc intermediate designed for use in targeted delivery conjugate synthesis. Its rigid multi-ring structure and high polarity facilitate the assembly of multivalent ligands for research applications.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 186613-57-0
(R)-(+)-2-Acetoxypropionic Acid
pharmaceutical intermediate
N5-[[[(2,3-Dihydro-2,2,4,6,7-pentamethyl-5-benzofuranyl)sulfonyl]amino]iminomethyl]-N2-[(1,1-dimethylethoxy)carbonyl]-D-ornithine
pharmaceutical intermediate
2,6-Dichloroquinoxaline
pharmaceutical intermediate
(3beta)-16-[(3beta)-3-(Acetyloxy)androsta-5,16-dien-17-yl]-17-(3-pyridinyl)-androsta-5,16-dien-3-ol 3-Acetate
pharmaceutical intermediate
5-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dibenzoyloxy-6-(benzoyloxymethyl)oxan-2-yl]oxypentanoic acid
OZBZNGCNHUNODU-AWVJDWFHSA-N
CC(=O)N[C@@H]1[C@H]([C@H]([C@H](O[C@H]1OCCCCC(=O)O)COC(=O)C2=CC=CC=C2)OC(=O)C3=CC=CC=C3)OC(=O)C4=CC=CC=C4